Horizon Therapeutics Usa, Inc. drugs

10 results
  • actimmune - interferon gamma-1b injection, solution

    (Interferon Gamma-1b)
    Horizon Therapeutics Usa, Inc.
    Actimmune reduces the frequency and severity of serious infections in Chronic Granulomatous Disease (CGD) and delays disease progression in severe, malignant osteopetrosis (SMO).
  • krystexxa - pegloticase injection, solution

    (Pegloticase)
    Horizon Therapeutics Usa, Inc.
    KRYSTEXXA treats chronic gout in adults who have not responded to conventional therapy, including those who cannot tolerate or have failed xanthine oxidase inhibitors at maximum appropriate doses. Not for asymptomatic hyperuricemia.
  • procysbi - cysteamine bitartrate capsule, delayed release pellets

    (Cysteamine Bitartrate)
    Horizon Therapeutics Usa, Inc.
    Procysbi treats nephropathic cystinosis in adults and children 1 year of age and older.
  • rayos

    (Prednisone)
    Horizon Therapeutics Usa, Inc.
    Rayos (prednisone) treats a wide range of inflammatory and autoimmune conditions including allergic reactions, skin diseases, rheumatologic disorders, respiratory conditions, hematologic diseases, organ transplant rejection, and certain cancers in adults and children.
  • tepezza - teprotumumab injection, powder, lyophilized, for solution

    (Teprotumumab)
    Horizon Therapeutics Usa, Inc.
    TEPEZZA is indicated for the treatment of Thyroid Eye Disease in adults, regardless of disease activity or duration.
  • uplizna - inebilizumab injection

    (Inebilizumab)
    Horizon Therapeutics Usa, Inc.
    Uplizna treats NMOSD in AQP4 antibody-positive adults, IgG4-related disease in adults, and generalized myasthenia gravis in adults who are AChR or MuSK antibody positive.
  • vimovo

    (Naproxen And Esomeprazole Magnesium)
    Horizon Therapeutics Usa, Inc.
    Vimovo (naproxen/esomeprazole) treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis in adults, and juvenile idiopathic arthritis in adolescents 12+ years weighing at least 38 kg, while reducing the risk of naproxen-associated gastric ulcers.